BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 24362093)

  • 1. Oxidation of carcinogenic benzo[a]pyrene by human and rat cytochrome P450 1A1 and its influencing by cytochrome b5 - a comparative study.
    Indra R; Moserova M; Sulc M; Frei E; Stiborova M
    Neuro Endocrinol Lett; 2013; 34 Suppl 2():55-63. PubMed ID: 24362093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome b5 and epoxide hydrolase contribute to benzo[a]pyrene-DNA adduct formation catalyzed by cytochrome P450 1A1 under low NADPH:P450 oxidoreductase conditions.
    Stiborová M; Moserová M; Černá V; Indra R; Dračínský M; Šulc M; Henderson CJ; Wolf CR; Schmeiser HH; Phillips DH; Frei E; Arlt VM
    Toxicology; 2014 Apr; 318():1-12. PubMed ID: 24530354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of human cytochrome P450 1A1-mediated oxidation of benzo[a]pyrene by NADPH:cytochrome P450 oxidoreductase and cytochrome b5.
    Indra R; Moserova M; Kroftova N; Sulc M; Martinkova M; Adam V; Eckschlager T; Kizek R; Arlt VM; Stiborova M
    Neuro Endocrinol Lett; 2014; 35 Suppl 2():105-13. PubMed ID: 25638374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NADPH- and NADH-dependent metabolism of and DNA adduct formation by benzo[
    Stiborová M; Indra R; Moserová M; Šulc M; Hodek P; Frei E; Schmeiser HH; Arlt VM
    Monatsh Chem; 2016; 147():847-855. PubMed ID: 27110038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NADH:Cytochrome b5 Reductase and Cytochrome b5 Can Act as Sole Electron Donors to Human Cytochrome P450 1A1-Mediated Oxidation and DNA Adduct Formation by Benzo[a]pyrene.
    Stiborová M; Indra R; Moserová M; Frei E; Schmeiser HH; Kopka K; Phillips DH; Arlt VM
    Chem Res Toxicol; 2016 Aug; 29(8):1325-34. PubMed ID: 27404282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of individual cytochrome P450 enzymes on oxidative metabolism of benzo[a]pyrene in human livers.
    Šulc M; Indra R; Moserová M; Schmeiser HH; Frei E; Arlt VM; Stiborová M
    Environ Mol Mutagen; 2016 Apr; 57(3):229-35. PubMed ID: 26919089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.
    Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC
    Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between DNA adduct formation by benzo[a]pyrene and expression of its activation enzyme cytochrome P450 1A1 in rat.
    Hodek P; Koblihová J; Kizek R; Frei E; Arlt VM; Stiborová M
    Environ Toxicol Pharmacol; 2013 Nov; 36(3):989-96. PubMed ID: 24095716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzo[
    Dračínská H; Indra R; Jelínková S; Černá V; Arlt VM; Stiborová M
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudan I is a potential carcinogen for humans: evidence for its metabolic activation and detoxication by human recombinant cytochrome P450 1A1 and liver microsomes.
    Stiborová M; Martínek V; Rýdlová H; Hodek P; Frei E
    Cancer Res; 2002 Oct; 62(20):5678-84. PubMed ID: 12384524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of benzo[a]pyrene metabolites formed by rat hepatic microsomes using high pressure liquid chromatography: optimization of the method.
    Moserová M; Kotrbová V; Aimová D; Sulc M; Frei E; Stiborová M
    Interdiscip Toxicol; 2009 Dec; 2(4):239-44. PubMed ID: 21217860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cytochromes P450 in metabolism of carcinogenic aristolochic acid I: evidence of their contribution to aristolochic acid I detoxication and activation in rat liver.
    Stiborova M; Mares J; Levova K; Pavlickova J; Barta F; Hodek P; Frei E; Schmeiser HH
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():121-30. PubMed ID: 22167220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to endocrine disruptors 17alpha-ethinylestradiol and estradiol influences cytochrome P450 1A1-mediated genotoxicity of benzo[a]pyrene and expression of this enzyme in rats.
    Stiborová M; Dračínská H; Bořek-Dohalská L; Klusoňová Z; Holecová J; Martínková M; Schmeiser HH; Arlt VM
    Toxicology; 2018 May; 400-401():48-56. PubMed ID: 29649501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of benzo[a]pyrene to trans-7,8-dihydroxy-7, 8-dihydrobenzo[a]pyrene by recombinant human cytochrome P450 1B1 and purified liver epoxide hydrolase.
    Shimada T; Gillam EM; Oda Y; Tsumura F; Sutter TR; Guengerich FP; Inoue K
    Chem Res Toxicol; 1999 Jul; 12(7):623-9. PubMed ID: 10409402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro metabolism of benzo[a]pyrene by recombinant zebrafish CYP1A and liver microsomes from beta-naphthoflavone-treated rainbow trout.
    Miranda CL; Chung WG; Wang-Buhler JL; Musafia-Jeknic T; Baird WM; Buhler DR
    Aquat Toxicol; 2006 Nov; 80(2):101-8. PubMed ID: 16963132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to benzo[a]pyrene of Hepatic Cytochrome P450 Reductase Null (HRN) and P450 Reductase Conditional Null (RCN) mice: Detection of benzo[a]pyrene diol epoxide-DNA adducts by immunohistochemistry and 32P-postlabelling.
    Arlt VM; Poirier MC; Sykes SE; John K; Moserova M; Stiborova M; Wolf CR; Henderson CJ; Phillips DH
    Toxicol Lett; 2012 Sep; 213(2):160-6. PubMed ID: 22759596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of low-level short-term o-xylene inhalation of benzo[a]pyrene (BaP) metabolism and BaP-DNA adduct formation in rat liver and lung microsomes.
    Park SH; Schatz RA
    J Toxicol Environ Health A; 1999 Nov; 58(5):299-312. PubMed ID: 10598955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel, sensitive method for determining benzo[a]pyrene-diones using high-performance liquid chromatography with post-column zinc reduction.
    Liao KH; Mayeno AN; Reardon KF; Yang RS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):166-74. PubMed ID: 16061434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants.
    Schwarz D; Kisselev P; Cascorbi I; Schunck WH; Roots I
    Carcinogenesis; 2001 Mar; 22(3):453-9. PubMed ID: 11238186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice.
    Arlt VM; Stiborová M; Henderson CJ; Thiemann M; Frei E; Aimová D; Singh R; Gamboa da Costa G; Schmitz OJ; Farmer PB; Wolf CR; Phillips DH
    Carcinogenesis; 2008 Mar; 29(3):656-65. PubMed ID: 18204078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.